Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
274 hedge funds and large institutions have $510M invested in Avanos Medical in 2025 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 82 increasing their positions, 89 reducing their positions, and 36 closing their positions.
30% more call options, than puts
Call options by funds: $257K | Put options by funds: $198K
3% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 36
0.81% more ownership
Funds ownership: 96.97% → 97.78% (+0.81%)
1% less funds holding
Funds holding: 276 → 274 (-2)
2% less capital invested
Capital invested by funds: $520M → $510M (-$10.3M)
8% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 89
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$8.01M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$6.02M |
| 3 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
+$3.09M |
| 4 |
Morgan Stanley
New York
|
+$2.99M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$2.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$3.8M |
| 2 |
JP Morgan Chase
New York
|
-$3.48M |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
-$3.33M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$2.78M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.23M |
AVNS Hedge Fund Activity: Q4 2025 in Review
274 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2025, worth a combined $510M — down 2% from $520M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new AVNS positions and 36 closed out — a net gain of 1 holder — while 82 added to existing stakes and 89 trimmed.
The largest buyer was Armistice Capital, adding an estimated $8.01M. The largest seller was Pacer Advisors, exiting entirely with an estimated $3.8M sold.
- 274 institutional investors held Avanos Medical (AVNS) as of Q4 2025, down from 276 in Q3 2025.
- Funds reported $510M of Avanos Medical stock for Q4 2025, down 2% quarter-over-quarter.
- 37 funds opened new Avanos Medical positions in Q4 2025 and 36 closed out, a net change of +1 holder.
- The largest Avanos Medical buyer in Q4 2025 was Armistice Capital, an estimated $8.01M added.
- The largest Avanos Medical seller in Q4 2025 was Pacer Advisors, an estimated $3.8M sold.
Based on aggregated 13F filings for Q4 2025.